Molecular diagnostic testing as an adjunct to morphologic evaluation of pacreatic ductal system brushing: Potential augmentation for diagnostic sensitivity

Diagnostic Cytopathology

Volumn 35, Issue 4, 2007, Pages 218-224

  Willmore Payne, Carlynn ^d   Volmar, Keith E ^a   Huening, Michael A ^b   Holden, Joseph A ^c   Layfield, Lester J ^c  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^d ARUP LABORATORIES   (United States)

Author keywords

B raf; EGFR; K ras; Mutation analysis; p53; Pancreatic duct brushings

Indexed keywords

ARTICLE; BRAF GENE; CANCER CYTODIAGNOSIS; CLINICAL ARTICLE; EGFR GENE; GENE; GENE MUTATION; HUMAN; HUMAN TISSUE; MUTATIONAL ANALYSIS; NUCLEOTIDE SEQUENCE; ONCOGENE K RAS; PANCREAS ADENOCARCINOMA; PANCREAS DUCT; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

CARCINOMA, PANCREATIC DUCTAL; DNA MUTATIONAL ANALYSIS; GENES, RAS; HUMANS; IMMUNOHISTOCHEMISTRY; MOLECULAR DIAGNOSTIC TECHNIQUES; MUTATION; PANCREATIC NEOPLASMS; POLYMERASE CHAIN REACTION; PROTO-ONCOGENE PROTEINS B-RAF; RECEPTOR, EPIDERMAL GROWTH FACTOR; SENSITIVITY AND SPECIFICITY; TUMOR SUPPRESSOR PROTEIN P53;

EID: 34047129200     PISSN: 87551039     EISSN: 10970339     Source Type: Journal    
DOI: 10.1002/dc.20608     Document Type: Article

References (23)

1. Warshaw AL, Castillo CFD. Pancreatic carcinoma. N Engl J Med 1992;326:455-465.
2. de Peralta-Venturina MN, Wong DK, Purslow MJ, et al. Biliary tract cytology in specimens obtained by direct cholangiographic procedures: A study of 74 cases. Diagn Cytopathol 1996;14:334-348.
3. Geisinger KR. Alimentary tract (esophagus, stomach, small intestine, colon, rectum, anus, biliary tract). In: Bibbo M, editor. Comprehensive cytopathology. 2nd ed. Philadelphia: W. B. Saunders; 1997. p 413-434.
4. Ishimaru S, Itah M, Hanada K, et al. Immunocytochemical detection of p53 protein pancreatic duct brushings in patients with pancreatic carcinoma. Cancer 1996;77:2233-2239.
5. Layfield LJ, Wax TD, Lee JG, et al. Accuracy and morphologic aspects of pancreatic and biliary duct brushings. Acta Cytol 1995;39:11-18.
6. Kocjan G, Smith AN. Bile duct brushing cytology: Potential pitfalls in diagnosis. Diagn Cytopathol 1997;16:358-363.
7. Dardales RH, Stanley MW, Simpson DD, et al. Diagnostic value of brush cytology in the diagnosis of duodenal, biliary and ampullary neoplasms. Am J Clin Pathol 1998;109:540-548.
8. Renshaw AA, Madge R, Jiroutek M, et al. Bile duct brushing cytology. Statistical analysis of proposed diagnostic criteria. Am J Clin Pathol 1998;110:635-640.
9. Tada M, Ohashi M, Shiratori Y, et al. Analysis of K-ras gene mutation in hyperplastic duct cells of the pancreas without pancreatic disease. Gastroenterol 1996;110:227-231.
10. Lüttges J, Schlehe B, Menke MAOH, Vogel I, Heene-Bruns D, Klöppel G. The K-ras mutation pattern in pancreatic ductal adenocarcinoma usually is identical to that in associated normal, hyperplastic, and metaplastic ductal epithelium. Cancer 1999;85:1703-1710.
11. Moskaluk CA, Hruban RH, Kern SE. p16 and K-ras gene mutations in the intraductal precursors of human pancreatic adenocarinoma. Cancer Res 1997;57:2140-2143.
12. Terhune PG, Phifer DM, Tosteson TD, Longnecker DS. K-ras mutation in focal proliferative lesions of human pancreas. Cancer Epidemiol Biomarkers Prev 1998;7:515-521.
13. Wilentz RE, Geradts J, Marynard R, et al. Inactivation of the p16 (INK4A) tumor-suppressor gene in pancreatic duct lesions: Loss of intranuclear expression. Cancer Res 1998;58:4740-4744.
14. Wang Y, Yamaguchi Y, Watanabe H, et al. Detection of p53 gene mutations in the supernatant of pancreatic juice and plasma from patients with pancreatic carcinomas. Pancreas 2004;28:13-19.
15. Lüttges J, Galehdari H, Bröcker V, et al. Allelic loss is often the first hit in the biallelic inactivation of the p53 and DCP4 genes during pancreatic carcinogenesis. Am J Pathol 2001;158:1677-1683.
16. Biankin AV, Kench JG, Dijkman FP, Biankin SA, Henshall SM. Molecular pathogenesis of precursor lesions of pancreatic ductal adenocarcinoma. Pathology 2003;35:14-24.
17. Hruban RH, Goggins M, Parsons J, Kern SE. Progression model for pancreatic cancer. Clin Cancer Res 2000;6:2969-2972.
18. Goggins M, Hruban RH, Kern SE. BRCA2 is inactivated late in the development of pancreatic intraepithelial neoplasia. Evidence and implications. Am J Pathol 2000;156:1767-1771.
19. Klein WM, Hruban RH, Klein-Szanto AJP, Wilentz RE. Direct correlation between proliferative activity and dysplasia in pancreatic intraepithelial neoplasia (Pan IN): Additional evidence for a recently proposed model of progression. Mod Pathol 2002;15:441-447.
20. Willmore C, Holden JA, Zhou L, Tripp S, Wittwer CT, Layfield LJ. Detection of c-kit activating mutations in gastrointestinal stromal tumors by high resolution amplicon melting analysis. AJCP 2004;122:206-216.
21. Willmore-Payne C, Layfield LJ, Holden JA. C-kit mutational analysis for diagnosis of gastrointestinal stromal tumors in fine-needle aspiration specimens. Cancer (Cytopathol) 2005;105:165-170.
22. Volmar KE, Vollmer RT, Routbort MJ, Creager AJ. Pancreatic and bile duct brushing cytology in 1,000 cases: review of findings and comparison of preparation methods. Cancer 2006;108:231-238.
23. Sturm PD, Hruban RH, Ramsoekh TB, et al. The potential diagnostic use of K-ras codon 12 and p53 alterations in brush cytology from the pancreatic head region. J Pathol 1998;186:247-253.